Cargando…
Comparison of Target Enrichment Platforms for Circulating Tumor DNA Detection
Cancer-related mortality of solid tumors remains the major cause of death worldwide. Circulating tumor DNA (ctDNA) released from cancer cells harbors specific somatic mutations. Sequencing ctDNA opens opportunities to non-invasive population screening and lays foundations for personalized therapy. I...
Autores principales: | Lam, So Ngo, Zhou, Ying Chun, Chan, Yee Man, Foo, Ching Man, Lee, Po Yi, Mok, Wing Yeung, Wong, Wing Sum, Fung, Yan Yee, Wong, Kit Yee, Huang, Jun Yuan, Chow, Chun Kin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057974/ https://www.ncbi.nlm.nih.gov/pubmed/32139724 http://dx.doi.org/10.1038/s41598-020-60375-x |
Ejemplares similares
-
Tracking the Transcription Kinetic of SARS-CoV-2 in Human Cells by Reverse Transcription-Droplet Digital PCR
por: Au, Ka-Ki, et al.
Publicado: (2021) -
How much do elders with chronic conditions know about their medications?
por: Chan, Frank Wan-kin, et al.
Publicado: (2013) -
Succinct workflows for circulating tumor cells after enrichment: From systematic counting to mutational profiling
por: Wong, Victor Chun-Lam, et al.
Publicado: (2017) -
Noninvasive prenatal paternity testing by means of SNP‐based targeted sequencing
por: Tam, Jacqueline Chor Wing, et al.
Publicado: (2020) -
Identification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer
por: Li, Hongjian, et al.
Publicado: (2017)